 Community-Acquired Infections
"Community-Acquired Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any infection acquired in the community, that is, contrasted with those acquired in a health care facility (CROSS INFECTION). An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility.
| Descriptor ID |
D017714
|
| MeSH Number(s) |
C01.539.234
|
| Concept/Terms |
Community-Acquired Infections- Community-Acquired Infections
- Community Acquired Infections
- Infections, Community-Acquired
- Community-Acquired Infection
- Infection, Community-Acquired
- Infections, Community Acquired
|
Below are MeSH descriptors whose meaning is more general than "Community-Acquired Infections".
Below are MeSH descriptors whose meaning is more specific than "Community-Acquired Infections".
This graph shows the total number of publications written about "Community-Acquired Infections" by people in UAMS Profiles by year, and whether "Community-Acquired Infections" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2025 | 1 | 2 | 3 | | 2024 | 2 | 0 | 2 | | 2023 | 1 | 0 | 1 | | 2022 | 2 | 0 | 2 | | 2021 | 1 | 1 | 2 | | 2020 | 0 | 1 | 1 | | 2019 | 1 | 0 | 1 | | 2018 | 0 | 1 | 1 | | 2017 | 0 | 1 | 1 | | 2016 | 0 | 1 | 1 | | 2015 | 1 | 0 | 1 | | 2014 | 0 | 1 | 1 | | 2013 | 0 | 2 | 2 | | 2012 | 1 | 3 | 4 | | 2011 | 0 | 2 | 2 | | 2009 | 1 | 0 | 1 | | 2007 | 1 | 1 | 2 | | 2006 | 0 | 2 | 2 | | 2004 | 1 | 2 | 3 | | 2003 | 1 | 2 | 3 | | 2002 | 1 | 1 | 2 | | 2000 | 0 | 1 | 1 | | 1999 | 1 | 0 | 1 | | 1997 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Community-Acquired Infections" by people in Profiles over the past ten years.
-
Lloyd EC, Wolf J. Empiric Antibiotic Therapy for Mycoplasma pneumoniae Pneumonia in Children: A Pro/Con Discussion. J Pediatric Infect Dis Soc. 2025 Sep 11; 14(9).
-
Thomas T, Moore A, Nath S, Kearns G. A silent opponent: Staphylococcus aureus and its impact on wrestlers. Int J Sports Med. 2025 Jun; 46(6):383-389.
-
Nathavitharana RR, Pearl A, Biewer A, Young L, Mukasa L, Delrooz N, Subramanian A, Miller S, Mase S, Munsiff SS, Nardell E. Effects of Respiratory Isolation for Tuberculosis to Reduce Community-based Transmission: A Systematic Review. Clin Infect Dis. 2025 02 05; 80(1):189-198.
-
Daneman N, Rishu A, Pinto R, Rogers BA, Shehabi Y, Parke R, Cook D, Arabi Y, Muscedere J, Reynolds S, Hall R, Dwivedi DB, McArthur C, McGuinness S, Yahav D, Coburn B, Geagea A, Das P, Shin P, Detsky M, Morris A, Fralick M, Powis JE, Kandel C, Sligl W, Bagshaw SM, Singhal N, Belley-Cote E, Whitlock R, Khwaja K, Morpeth S, Kazemi A, Williams A, MacFadden DR, McIntyre L, Tsang J, Lamontagne F, Carignan A, Marshall J, Friedrich JO, Cirone R, Downing M, Graham C, Davis J, Duan E, Neary J, Evans G, Alraddadi B, Al Johani S, Martin C, Elsayed S, Ball I, Lauzier F, Turgeon A, Stelfox HT, Conly J, McDonald EG, Lee TC, Sullivan R, Grant J, Kagan I, Young P, Lawrence C, O'Callaghan K, Eustace M, Choong K, Aslanian P, Buehner U, Havey T, Binnie A, Prazak J, Reeve B, Litton E, Lother S, Kumar A, Zarychanski R, Hoffman T, Paterson D, Daley P, Commons RJ, Charbonney E, Naud JF, Roberts S, Tiruvoipati R, Gupta S, Wood G, Shum O, Miyakis S, Dodek P, Kwok C, Fowler RA. Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections. N Engl J Med. 2025 Mar 13; 392(11):1065-1078.
-
Li Y, Zhu D, Sun S, Chang X, Cao Z, Yang Y, Fu X, Li X, Xu J, Zhu Y, Hui F, Xu X, Chen Z, Peng L, Ma Z, Mo B, Li C, Lv Y, Zhao L, Zhu G, He Y, Liu H, Chen J, Wang Y, Liang Y, Lu Y, Qin Z, Yang H, Zhang M, Wu S, Tong Z, Ye F, Xiao Z, Wang X, Qiu C, Kuang J, Huang H, Wang K, Ying K, Jin F, Lv X, Huang Y, Liu D, Wang W, Zhang Y. A multicentre, randomised, double-blind, double-dummy, parallel-controlled, phase 3 clinical trial assessing the efficacy and safety of intravenous nemonoxacin malate vs. levofloxacin for community-acquired pneumonia in adult patients. Int J Antimicrob Agents. 2024 Aug; 64(2):107235.
-
Kasotakis G, Pant P, Patel AD, Ahmed Y, Raghunathan K, Krishnamoorthy V, Ohnuma T. Hospital Outcomes in Patients Who Developed Acute Respiratory Distress Syndrome After Community-Acquired Pneumonia. J Intensive Care Med. 2024 Oct; 39(10):994-1001.
-
Wilkins H, Hobart-Porter N, Eastin C. What is the Optimal Treatment Duration for Outpatient Pediatric Community-Acquired Pneumonia? Ann Emerg Med. 2024 Mar; 83(3):214-216.
-
Lang JE, Hornik CP, Elliott C, Silverstein A, Hornik C, Al-Uzri A, Bosheva M, Bradley JS, Borja-Tabora CFC, Di John D, Mendez Echevarria A, Ericson JE, Friedel D, Gonczi F, Isidro MGD, James LP, Kalocsai K, Koutroulis I, Laki I, Ong-Lim ALT, Nad M, Simon G, Syed S, Szabo E, Benjamin DK, Cohen-Wolkowiez M. Solithromycin in Children and Adolescents With Community-acquired Bacterial Pneumonia. Pediatr Infect Dis J. 2022 07 01; 41(7):556-562.
-
Nasrin S, Tariqujjaman M, Sultana M, Zaman RA, Ali S, Chisti MJ, Faruque ASG, Ahmed T, Fuchs GJ, Gyr N, Alam NH. Factors associated with community acquired severe pneumonia among under five children in Dhaka, Bangladesh: A case control analysis. PLoS One. 2022; 17(3):e0265871.
-
Diamond S, Vallejo JG, McNeil JC. Microbiology and Treatment Outcomes of Community-Acquired Hematogenous Osteoarticular Infections in Infants =12?Months of Age. J Pediatr. 2022 02; 241:242-246.e1.
-
Vang KE, Krow-Lucal ER, James AE, Cima MJ, Kothari A, Zohoori N, Porter A, Campbell EM. Participation in Fraternity and Sorority Activities and the Spread of COVID-19 Among Residential University Communities - Arkansas, August 21-September 5, 2020. MMWR Morb Mortal Wkly Rep. 2021 Jan 08; 70(1):20-23.
-
Zimmerman JJ, Banks R, Berg RA, Zuppa A, Newth CJ, Wessel D, Pollack MM, Meert KL, Hall MW, Quasney M, Sapru A, Carcillo JA, McQuillen PS, Mourani PM, Wong H, Chima RS, Holubkov R, Coleman W, Sorenson S, Varni JW, McGalliard J, Haaland W, Whitlock K, Dean JM, Reeder RW. Trajectory of Mortality and Health-Related Quality of Life Morbidity Following Community-Acquired Pediatric Septic Shock. Crit Care Med. 2020 03; 48(3):329-337.
-
Hassen M, Toma A, Tesfay M, Degafu E, Bekele S, Ayalew F, Gedefaw A, Tadesse BT. Radiologic Diagnosis and Hospitalization among Children with Severe Community Acquired Pneumonia: A Prospective Cohort Study. Biomed Res Int. 2019; 2019:6202405.
-
Gomi H, Solomkin JS, Schlossberg D, Okamoto K, Takada T, Strasberg SM, Ukai T, Endo I, Iwashita Y, Hibi T, Pitt HA, Matsunaga N, Takamori Y, Umezawa A, Asai K, Suzuki K, Han HS, Hwang TL, Mori Y, Yoon YS, Huang WS, Belli G, Dervenis C, Yokoe M, Kiriyama S, Itoi T, Jagannath P, Garden OJ, Miura F, de Santiba?es E, Shikata S, Noguchi Y, Wada K, Honda G, Supe AN, Yoshida M, Mayumi T, Gouma DJ, Deziel DJ, Liau KH, Chen MF, Liu KH, Su CH, Chan ACW, Yoon DS, Choi IS, Jonas E, Chen XP, Fan ST, Ker CG, Gim?nez ME, Kitano S, Inomata M, Mukai S, Higuchi R, Hirata K, Inui K, Sumiyama Y, Yamamoto M. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018 Jan; 25(1):3-16.
-
Britt RS, Evoy KE, Lee GC, Reveles KR, Sorensen KM, Jones X, Bollinger M, Frei CR. Early Use of Ceftaroline Fosamil in the United States Veterans Health Care System. Drugs. 2017 Aug; 77(12):1345-1351.
-
Huang LL, Van Schooneveld TC, Huang RD, Olsen KM, Rupp ME, Gross AE. Guideline-Concordant Versus Discordant Antimicrobial Therapy in Patients With Community-Onset Complicated Intra-abdominal Infections. Infect Control Hosp Epidemiol. 2016 07; 37(7):855-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|